Loading clinical trials...
Loading clinical trials...
A Randomised, Double Blind Placebo-controlled Trial Evaluating the Medical Food Synbiotic SBD121, Versus Placebo for the Clinical Dietary Management of Early Rheumatoid Arthritis.
Conditions
Interventions
SBD121
Placebo
Locations
22
Australia
Paratus Clinical Canberra
Canberra, Australian Capital Territory, Australia
Campbelltown Hospital
Campbelltown, New South Wales, Australia
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Genesis Research Services
Newcastle, New South Wales, Australia
BJC Health
Parramatta, New South Wales, Australia
Start Date
September 30, 2023
Primary Completion Date
October 6, 2025
Completion Date
October 6, 2025
Last Updated
December 18, 2025
NCT06647069
NCT07484243
NCT06841562
NCT07268326
NCT07233655
NCT07029555
Lead Sponsor
Solarea Bio, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions